Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-14 3:01 pm Sale |
2022-12-31 | 13G | Sierra Oncology, Inc. SRRA |
Rock Springs Capital Management LP | 0 0.000% |
-1,184,793 (Position Closed) |
Filing History |
| 2023-02-10 4:20 pm Sale |
2022-12-31 | 13G | Sierra Oncology, Inc. SRRA |
Versor Investments LP | 0 0.000% |
-1,266,927 (Position Closed) |
Filing History |
| 2022-07-11 4:30 pm Sale |
2022-07-01 | 13D | Sierra Oncology, Inc. SRRA |
Abingworth LLP | 0 0.000% |
-2,193,626 (Position Closed) |
Filing History |
| 2022-07-05 5:06 pm Sale |
2022-07-01 | 13G | Sierra Oncology, Inc. SRRA |
Vivo Capital IX, LLC | 0 0.000% |
-2,735,852 (Position Closed) |
Filing History |
| 2022-05-06 4:33 pm Sale |
2022-04-27 | 13D | Sierra Oncology, Inc. SRRA |
Longitude Capital Partners III LLC | 1,485,140 5.700% |
-2,140,130 (-59.03%) |
Filing History |
| 2022-04-22 2:32 pm Purchase |
2022-04-14 | 13G | Sierra Oncology, Inc. SRRA |
Versor Investments LP | 1,266,927 5.300% |
1,266,927 (New Position) |
Filing History |
| 2022-03-29 4:23 pm Purchase |
2022-03-24 | 13G | Sierra Oncology, Inc. SRRA |
Frazier Life Sciences Public Fund, L.P. | 2,366,853 10.000% |
1,562,186 (+194.14%) |
Filing History |
| 2022-03-21 4:52 pm Unchanged |
2022-03-10 | 13D | Sierra Oncology, Inc. SRRA |
Abingworth LLP | 2,193,626 8.900% |
0 (Unchanged) |
Filing History |
| 2022-03-15 4:30 pm Unchanged |
2022-03-10 | 13D | Sierra Oncology, Inc. SRRA |
ORBIMED ADVISORS LLC | 3,044,753 12.200% |
0 (Unchanged) |
Filing History |
| 2022-02-14 6:25 pm Purchase |
2021-12-31 | 13G | Sierra Oncology, Inc. SRRA |
Rock Springs Capital Management LP | 1,184,793 7.870% |
617,435 (+108.83%) |
Filing History |
| 2022-02-14 4:21 pm Purchase |
2021-12-31 | 13G | Sierra Oncology, Inc. SRRA |
Venrock Healthcare Capital Partners II, L.P. | 984,746 6.100% |
979,565 (+18907.15%) |
Filing History |
| 2022-02-14 3:57 pm Sale |
2021-12-31 | 13G | Sierra Oncology, Inc. SRRA |
CAXTON CORP | 1,119,322 7.000% |
-23,039 (-2.02%) |
Filing History |
| 2022-02-11 5:22 pm Purchase |
2022-01-31 | 13G | Sierra Oncology, Inc. SRRA |
Vivo Capital IX, LLC | 2,735,852 14.700% |
799,999 (+41.33%) |
Filing History |
| 2022-02-11 4:57 pm Unchanged |
2021-12-31 | 13G | Sierra Oncology, Inc. SRRA |
New Leaf Biopharma Opportunities I L.P. | 787,414 4.100% |
0 (Unchanged) |
Filing History |
| 2022-02-10 5:00 pm Purchase |
2022-01-31 | 13D | Sierra Oncology, Inc. SRRA |
Abingworth LLP | 2,193,626 11.300% |
150,000 (+7.34%) |
Filing History |
| 2022-02-10 4:55 pm Purchase |
2021-12-31 | 13G | Sierra Oncology, Inc. SRRA |
GILEAD SCIENCES INC GILD |
1,450,566 9.200% |
377,266 (+35.15%) |
Filing History |
| 2022-02-10 10:54 am Purchase |
2021-12-31 | 13G | Sierra Oncology, Inc. SRRA |
ADAGE CAPITAL PARTNERS GP LLC | 1,230,468 8.170% |
436,328 (+54.94%) |
Filing History |
| 2022-02-07 5:12 pm Purchase |
2022-01-27 | 13G | Sierra Oncology, Inc. SRRA |
PFM Health Sciences, LP | 1,062,888 5.500% |
1,062,888 (New Position) |
Filing History |
| 2022-02-04 5:22 pm Purchase |
2022-01-25 | 13D | Sierra Oncology, Inc. SRRA |
Longitude Capital Partners III LLC | 3,625,270 17.400% |
175,000 (+5.07%) |
Filing History |
| 2022-02-02 4:33 pm Unchanged |
2022-01-31 | 13D | Sierra Oncology, Inc. SRRA |
ORBIMED ADVISORS LLC | 3,044,753 15.300% |
0 (Unchanged) |
Filing History |